Search by Drug Name or NDC

    NDC 70000-0221-03 Gentle Laxative 5 mg/1 Details

    Gentle Laxative 5 mg/1

    Gentle Laxative is a ORAL TABLET, DELAYED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Cardinal Health 110, LLC. DBA Leader. The primary component is BISACODYL.

    Product Information

    NDC 70000-0221
    Product ID 70000-0221_75e7c8cb-656c-47b6-917e-7708747cc2cf
    Associated GPIs 46200010000610
    GCN Sequence Number 002947
    GCN Sequence Number Description bisacodyl TABLET DR 5 MG ORAL
    HIC3 D6S
    HIC3 Description LAXATIVES AND CATHARTICS
    GCN 08762
    HICL Sequence Number 001301
    HICL Sequence Number Description BISACODYL
    Brand/Generic Generic
    Proprietary Name Gentle Laxative
    Proprietary Name Suffix n/a
    Non-Proprietary Name Bisacodyl
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name BISACODYL
    Labeler Name Cardinal Health 110, LLC. DBA Leader
    Pharmaceutical Class Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH DRUG
    Application Number 505G(a)(3)
    Listing Certified Through 2024-12-31

    Package

    NDC 70000-0221-03 (70000022103)

    NDC Package Code 70000-0221-3
    Billing NDC 70000022103
    Package 7 BLISTER PACK in 1 CARTON (70000-0221-3) / 25 TABLET, DELAYED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2002-03-25
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.03671
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description GENTLE LAXATIVE EC 5 MG TABLET
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis